Hikma And Richter Partner On Cariprazine In MENA Markets
Hikma and Richter enter into an agreement to supply and commercialise cariprazine, an antipsychotic treatment for patients suffering from schizophrenia, in 14 MENA markets.
Hikma and Richter enter into an agreement to supply and commercialise cariprazine, an antipsychotic treatment for patients suffering from schizophrenia, in 14 MENA markets.